Nolpaza control 20 mg

14 tablets

Manufacturer:

KRKA

Indications

Nolpaza Control is a drug that inhibits the secretion of hydrochloric acid in gastric juice, containing a proton pump inhibitor. It is indicated in adults for the treatment of symptoms of reflux, e.g. heartburn and regurgitation.

Composition

Each enteric-resistant tablet contains 20 mg of pantoprazole (Pantoprazolum) (as pantoprazole sodium semi-aquatic). Excipient with known effect: Each gastro-resistant tablet contains 18 mg of sorbitol.

Dosage

• The recommended dose is 1 tablet per day.
• Do not use daily dose greater than 20 mg.
• The medicine should be taken for at least 2-3 consecutive days.
• You should stop taking Nolpaza control when the symptoms disappear completely.
• You should consult your doctor if your symptoms do not improve after taking this medicine for a full 2 ​​weeks.
• Do not take Nolpaza control for longer than 4 weeks without talking to your doctor.

Packaging

14 tablets

MAH

KRKA

Read the instructions before use leaflet, which contains indications, contraindications, data on side effects and dosage as well as information on the use of the medicinal product, or consult a doctor or pharmacist, because any medicine used incorrectly poses a threat to your life or health.